|
|
Sotret - Newsfeeds
-
-
Currently, the only class of FDA approved drug to treat the cause of acne is isotretinoin. Manufactured by Hoffman La-Roche and marketed under the trade name Accutane in the U.S., and Roaccutane in Europe, this drug class was recently taken off the market ...
-
-
Swedish researchers analyzed data from nearly 6,000 people treated with the acne medication isotretinoin, marketed as Accutane, between 1980 and 1989. By the end of 2001, 128 of these patients were hospitalized because of a suicide attempt, and 17 male and ...
-
-
Even though all had taken a powerful skin-clearing medication (isotretinoin, aka Accutane), the connection wasn't the drug; it was acne itself. A third of the suicidal teens had made their first attempt months before starting the medication, and many made ...
-
-
Roche discontinued Accutane in June 2009 due to the increasing costs of the litigation, but a number of generic versions remain available under names such as Claravis, Sotret, Amnesteem and generic isotretinoin.
-
-
Accutane is also know by a number of generic names including Amnesteem, Claravis, Decutan, Istane, Sotret, Ratane, and Raccutane. These are all essentially the same drug. Accutane was originally intended as a treatment of severe acne and was never meant to ...
-
-
isotretinoin and other retinoids, amiodarone, ethambutol, chloroquine and hydroxychloroquine, tamoxifen, quetiapine, cyclo-oxygenase (COX)-2 inhibitors, erectile dysfunction agents and some herbal medications."
-
-
August 20, 2010 (WLS) -- There is new evidence that antibiotics used to help control severe acne may in a very small number of cases lead to bowel problems. Previous studies have suggested that the acne drug Isotretinoin ...
-
-
previous studies have suggested that the acne drug isotretinoin, known commonly by the brand name Accutane, might be the cause of inflammatory bowel disease in a small number of patients being treated for severe acne.
-
-
Sotret, Amnesteem and generic isotretinoin. The determination means that the FDA does not consider the drug’s removal from the market as a recall, and will not remove approval of the drug. Generic manufacturers can ...
-
-
Claravis and Sotret. Before its patent expired, Accutane reportedly had sales of $200 million a year. Accutane was pulled from the market in June, 2009 by its manufacturer. At the time, Roche said the drug was being ...
-
-
... acne to include adult acne, truncal acne, severe acne and patient handouts on a variety of acne medications including, topical retinoids (Differin, Epiduo , Retin A Micro), isotretinoin and oral antibiotics (minocycline, Solodyn). "Vivacare ...
-
-
One of the most popular but controversial treatment of cystic acne is Accutane or Isotretinoin. Honestly, it is very effective to clear severe acne nodules, but it can have very bad effects to your health and should be your last resort, really.
-
-
Significant loss in body weight (such as crash dieting, intensive physical regimens) and intake of certain medication (for example, isotretinoin used for treatment of severe acne or beta-blockers used for treatment of high blood pressure) are also ...
-
-
Patients with severe acne vulgaris have few treatment options other than oral isotretinoin, which affects all major acne-related pathogens and is the treatment of choice for severe forms of acne, including recalcitrant nodular acne or acne conglobata ...
-
-
Accutane is a form of vitamin A—isotretinoin—that was taken for three to six months to treat severe nodular acne. It worked by reducing the amount of oil released by the oil glands in the patient's skin. Accutane, manufactured by Roche Holding ...
-
-
However, generic versions of Accutane, including Claravis, Sotret and Amnesteem are still available. "There have been six Accutane lawsuits involving its ability to cause inflammatory bowel disease," Rowland says. "All six verdicts were for the ...
-
-
Some common prescription acne therapies include: oral antibiotics, birth control pills, isotretinoin and topical retinoids (vitamin A derivatives). One type of in-office treatment for acne is a chemical peel – the application of a substance that ...
-
-
In addition, Cipher is developing formulations of the pain reliever tramadol (tentative FDA approval in February 2009) and the acne treatment isotretinoin (FDA approvable letter in April 2007). Cipher is listed on the Toronto Stock Exchange under the ...
-
-
Explain that patients who used the acne medication isotretinoin (Accutane) were 1.68 times more likely to develop inflammatory bowel disease. Note that this study was published as an abstract and presented at a conference. These data and conclusions ...
Content provided by MSN. LegalView is not responsible for the accuracy of the information provided above.
|
|
